AstraZeneca’s said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial – only a tad lower than the level in an earlier report this week criticised for using outdated data. Interim data published on Monday had put the vaccine’s efficacy rate at 79% but had not included more recent infections,...
Top News:
Why Rest Feels Like Guilt for So Many Adults
What a “Good Day” Actually Looks Like (According to Real People)
The Quiet Burnout: When You’re Tired but Can’t Explain Why
Why Small Habits Matter More in Unstable Times
What ‘Home’ Means When You’ve Lived in 3 Countries
Raising Lebanese Kids Without Lebanon
The Accents We Keep and the Ones We Lose
How Lebanese Humor Changes Outside Lebanon
What Lebanese Abroad Miss That Has Nothing to Do With Food
8 Hobbies That Quietly Build Mental Toughness Without You Realizing It
5 Stoic Self Discipline Rules To Put Yourself First Without Feeling Selfish
The Art Of Self Reinvention: 8 Habits That Change Your Life From The Inside Out
Progress Over Perfection: How to Keep Going When You’re Not Motivated
12 Notes To Self You Should Remember Before The New Year
How Air Travel Will Change In 2026: Comfort, Costs And New Rules
Lebanese Cabinet Backs Financial Gap Law To Unlock Frozen Deposits
Silver Vs Nvidia: How A Metal Is Catching Up With The AI Giant
AI Boom Adds 500 Billion Dollars To US Tech Billionaires Net Worths
Groq Executives Join Nvidia In Strategic AI Chip Licensing Deal
Germany extends liquidity aid for pandemic companies until yearend
Germany has extended its liquidity aid program for pandemic-hit companies until the end of this year, the finance and economy ministries said on Thursday as Europe’s largest economy is struggling to contain a third wave of coronavirus infections. The government also decided to lift the upper limit for loans in the emergency program to a...
Belarus starts mass production of Russia’s Sputnik V vaccine ministry
Belarus’ health ministry said on Thursday the country had started mass producing Russia’s Sputnik V vaccine and planned to produce up to 500,000 doses of the shot per month. – Reuters
The first batch of AstraZeneca vaccine arrives in Beirut
The National News Agency correspondent at Rafic Hariri International Airport stated that the first batch of AstraZeneca vaccine had arrived in Beirut.
Merkel calls crisis meeting Wednesday over virus measures
Chancellor Angela Merkel has summoned the leaders of Germany’s 16 states to an unexpected crisis meeting on Wednesday amid a backlash over pandemic measures, the chief of her CDU party said. “The chancellor has invited the (regional leaders) at short notice for 11 o’clock today and I think that we will talk very critically there...
Health Ministry: 3,851 new Corona cases, 42 deaths
The Ministry of Public Health announced, on Tuesday, the registration of 3,851 new Corona infections, thus raising the cumulative number of confirmed cases to-date to 444,865. It also indicated that 42 deaths were recorded during the past 24 hours.
U.S. health body questions the robustness of AstraZeneca’s COVID-19 vaccine trial data
AstraZeneca Plc may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large-scale trial in the United States, a U.S. health agency said Tuesday, in a fresh setback for the shot. The concerns throw into question whether the British drugmaker can seek U.S. emergency use authorization for the vaccine in...
Russia confirms 4,474,610 Coronavirus cases, 95,818 deaths
Russia has confirmed 4,474,610 cases of coronavirus and 95,818 deaths, according to the national coronavirus information center. According to figures published by state statistics agency Rosstat, Russia’s real coronavirus death toll stands at 131,118, with the virus present in another 69,314 deaths.
Health Ministry: 1,471 new Corona cases, 51 deaths
The Ministry of Public Health announced, on Monday, the registration of 1,471 new Corona infections, thus raising the cumulative number of confirmed cases to-date to 441,014. It also indicated that 51 deaths were recorded during the past 24 hours.
AstraZeneca’s new trial data gives COVID-19 vaccine a boost in the U.S
AstraZeneca’s coronavirus vaccine received a major boost on Monday after data from a large trial showed it was safe and effective, potentially paving the way for its emergency authorization in the United States as countries in Asia accelerated its rollout. The trials in the United States, Chile, and Peru showed the vaccine was 79% effective...








